Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression

INTRODUCTION: Unboosted atazanavir (ATV) including regimens have been investigated as a ritonavir-sparing simplification strategy. No data are available on removal of one NRTI in subjects effectively treated with unboosted atazanavir+2NRTIs. We present the 48-week virological efficacy and safety of...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Int AIDS Soc
Главные авторы: Carbone, Alessia, Galli, Laura, Bigoloni, Alba, Bossolasco, Simona, Guffanti, Monica, Maillard, Miriam, Carini, Elisabetta, Salpietro, Stefania, Spagnuolo, Vincenzo, Gianotti, Nicola, Lazzarin, Adriano, Castagna, Antonella
Формат: Artigo
Язык:Inglês
Опубликовано: International AIDS Society 2014
Предметы:
Poster Sessions – Abstract P279
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4225246/
https://ncbi.nlm.nih.gov/pubmed/25397555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.17.4.19811
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы